% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rnai_inv rnai_inv Mar 2, 2012 8:20 AM Flag

    John M. Maraganore $650,000

    Don't get me started on this subject.

    Maraganore has really limited upside potential in this stock. just talk to all the shareholder who bought at $25+. They could have sold the company for $30+ years ago, easily, they could have bought TKMR, they could have done more deals and partnerships, they could have settled the lawsuits already. But no mr maraganore is only interested in his own job. The clinical results with TTR and PCS have had much to do with the run up. He has his qualities, but seriously, I have seen much better CEOs

    Stock Option (right to buy) $7.1 11/30/2011 A 150,000 (1) 11/30/2021

    SortNewest  |  Oldest  |  Most Replied Expand all replies
69.2629-0.0871(-0.13%)9:46 AMEDT